// App-Quantinova.ai

S5041 2016 AHA : Safety and Efficacy of Peri-Procedural Heparin Plus Short Term Infusion of Tirofiban Versus Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: Results From The Intermountain Heart Collaborative Study

Researchers

Presenter

  • Heidi T May

Principal Investigators

  • Tami L Bair

  • Viet T Le

  • Jeffrey L Anderson

  • Brian K Whisenant

  • Kirk U Knowlton

  • Donald L Lappe

Medical Centers

  • Intermountain Med Ctr, Murray, UT

  • Intermountain Medical Ctr, Univ of California San Diego, Murray, UT

  • Intermountain Medical Ctr, Univ of Utah, Murray, UT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Cardiogenic shock

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Tirofiban hydrocloride

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved